Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A cohort of patients responsive to treatment with ranibizumab but resistant to
aflibercept were identified in a previously conducted retrospective study. Identified
patients will have their blood drawn for genome wide sequencing. The sequencing
data will be compiled and analyzed in an attempt to identify a common genetic basis
for patients susceptible to ranibizumab but resistant to aflibercept.